###begin article-title 0
AMP-ACTIVATED PROTEIN KINASE MEDIATES VEGF-STIMULATED ENDOTHELIAL NO PRODUCTION
###end article-title 0
###begin p 1
###xml 845 847 845 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 937 939 937 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Vascular endothelial growth factor (VEGF) is an important regulator of endothelial cell function. VEGF stimulates NO production, proposed to be a result of phosphorylation and activation of endothelial NO synthase (eNOS) at Ser1177. Phosphorylation of eNOS at this site also occurs after activation of AMP-activated protein kinase (AMPK) in cultured endothelial cells. We therefore determined whether AMPK mediates VEGF-stimulated NO synthesis in endothelial cells. VEGF caused a rapid, dose-dependent stimulation of AMPK activity, with a concomitant increase in phosphorylation of eNOS at Ser1177. Infection of endothelial cells with an adenovirus expressing a dominant negative mutant AMPK partially inhibited both VEGF-stimulated eNOS Ser1177 phosphorylation and NO production. VEGF-stimulated AMPK activity was completely inhibited by the Ca2+/calmodulin-dependent protein kinase kinase inhibitor, STO-609. Stimulation of AMPK via Ca2+/calmodulin-dependent protein kinase kinase represents a novel signalling mechanism utilised by VEGF in endothelial cells that contributes to eNOS phosphorylation and NO production.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 373 374 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 375 376 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
VEGF is a key regulator of angiogenesis, stimulating differentiation, survival, migration, proliferation and vascular permeability of endothelial cells [1,2]. VEGF binds to VEGF receptor tyrosine kinases, which have been demonstrated to stimulate a diverse array of signalling pathways, including phospholipase C (PLC)-gamma, phosphatidylinositol 3'-kinase (PI3K) and Src [1,2].
###end p 3
###begin p 4
###xml 50 51 50 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">6</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">7</xref>
VEGF rapidly stimulates endothelial NO synthesis [3-5], proposed to be the result of PI3K-mediated activation of protein kinase B (PKB, also known as Akt), which directly phosphorylates and activates eNOS at Ser1177 [4,6]. However, VEGF-stimulated NO production has been reported to be only partially inhibited by wortmannin, suggesting that VEGF-stimulated NO production is mediated by both PI3K/PKB and a PI3K-independent kinase [3,5,7].
###end p 4
###begin p 5
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 238 240 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 322 324 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 325 327 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 475 477 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 478 480 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">11</xref>
###xml 542 544 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 599 601 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">11</xref>
###xml 602 604 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 755 756 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 757 759 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">14</xref>
###xml 760 762 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
###xml 864 866 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 867 869 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 1102 1107 <span type="species:ncbi:9606">human</span>
In addition to PKB, AMPK has been shown to phosphorylate and activate eNOS at Ser1177 in cultured endothelial cells [8,9]. AMPK is activated by phosphorylation at Thr172 by at least two recently characterised upstream kinases, LKB1 and Ca2+/calmodulin-dependent protein kinase kinase (CaMKK), especially the beta isoform [10-13]. It has been proposed that the phosphorylation of AMPK by LKB1 is triggered by metabolic stresses that increase the intracellular AMP: ATP ratio [10,11], while phosphorylation and activation of AMPK by CaMKK is Ca2+-dependent and independent of changes in cellular AMP [11-13]. A key role for AMPK in the mediation of eNOS phosphorylation has been demonstrated in response to hypoxia, metformin, adiponectin and shear stress [9,14-17]. In addition, AMPK has been proposed to mediate angiogenesis stimulated by adiponectin and hypoxia [15,18]. AMPK therefore represents a candidate PI3K-independent kinase that underlies VEGF-stimulated eNOS phosphorylation. In this study we have investigated whether VEGF-stimulated NO production is mediated, in part, by AMPK in cultured human aortic endothelial cells (HAECs).
###end p 5
###begin title 6
METHODS
###end title 6
###begin title 7
Materials
###end title 7
###begin p 8
###xml 108 111 108 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 810 811 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 290 296 <span type="species:ncbi:9986">Rabbit</span>
###xml 359 362 <span type="species:ncbi:10116">rat</span>
###xml 437 441 <span type="species:ncbi:9925">Goat</span>
###xml 462 467 <span type="species:ncbi:10090">mouse</span>
###xml 559 565 <span type="species:ncbi:9986">Rabbit</span>
HAECs and endothelial cell culture media were obtained from TCS Cellworks (Botolph Claydon, Bucks, UK). VEGF165 and U73122 were supplied by Sigma (Poole, Dorset, UK). STO-609 was from Tocris (Ellisville, MO, USA). PP1 was a generous gift from Prof. G. Milligan, University of Glasgow, U.K. Rabbit anti-acetyl CoA carboxylase (ACC) and anti-phospho-ACC Ser79 (rat ACC1 sequence) antibodies were supplied by Upstate (Lake Placid NY, USA). Goat anti-CaMKKalpha and mouse anti-CaMKKbeta antibodies were supplied by Santa Cruz Biotechnology (Heidelberg, Germany). Rabbit anti-phospho-AMPK Thr172 antibodies were obtained from Cell Signaling Technology (Beverly MA, USA). SAMS peptide (HMRSAMSGLHLVKRR) was synthesised by Pepceuticals Ltd (Nottingham, UK). All other reagents were from sources described previously [9].
###end p 8
###begin title 9
Cell culture
###end title 9
###begin p 10
###xml 79 80 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
HAECs were grown in large vessel endothelial cell medium at 37degreesC in 5% CO2 and used for experiments between passages 3 and 6.
###end p 10
###begin title 11
Preparation of cell lysates and AMPK assay
###end title 11
###begin p 12
###xml 131 132 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 157 158 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 171 172 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 181 182 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 184 185 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 399 400 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
Cells were preincubated for 2 h at 37degreesC in 5 ml Krebs Ringer HEPES (KRH) buffer (119 mM NaCl, 20 mM HEPES, pH 7.4, 5 mM NaHCO3, 4.7 mM KCl, 1.3 mM CaCl2, 1.2 mM MgSO4, 1 mM KH2PO4, 0.1 mM L-arginine, 5 mM glucose). After addition of test substances for various durations, lysates were prepared, AMPK was immunoprecipitated and assayed using the SAMS substrate peptide as described previously [9].
###end p 12
###begin title 13
Adenoviruses and infection of HAECs
###end title 13
###begin p 14
###xml 246 247 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 250 250 246 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 469 470 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
Control (Ad.Null) and recombinant adenovirus expressing dominant negative AMPK (Ad.alpha1DN) were a generous gift from Dr F. Foufelle, Centre Biomedical des Cordeliers, Paris. Viruses were propagated, purified and stored as described previously [9].  HAECs were infected with 25 Pfu/cell adenovirus and cultured for 24 h prior to experimentation. Within 24 h of infection with a GFP-expressing virus, the majority (>95%) of HAECs expressed GFP as previously described [9].
###end p 14
###begin title 15
Assay of NO production in endothelial cells
###end title 15
###begin p 16
###xml 413 414 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
Cells cultured in 6-well plates were preincubated for 2 h at 37degreesC in 0.5 ml/well KRH buffer at 37degreesC. The media was removed and replaced with 0.4 ml fresh KRH buffer in the presence or absence of VEGF (10ng/ml), wortmannin (100nM) and/or L-NAME (1mM) for 15 min. The medium was removed, NO- specific chemiluminescence was analysed and L-NAME-sensitive NO production calculated as described previously [9].
###end p 16
###begin title 17
Immunoprecipitation of CaMKKbeta
###end title 17
###begin p 18
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
HAEC lysates (100 mug) were added to 0.5 mug mouse anti- CaMKKbeta antibody and mixed overnight at 4degreesC. Protein G-Sepharose (20 mul of 25% slurry) was added, the volume adjusted to 300 mul with lysis buffer and mixed for 4 h at 4degreesC. The mixture was centrifuged (14,000 x g, 30 s, 4degreesC) and the pellet washed 3 times in lysis buffer.
###end p 18
###begin title 19
Statistics
###end title 19
###begin p 20
Unless stated otherwise, results are expressed as mean +/- SD. Statistically significant differences were determined using a Student's t-test, using p<0.05 as significant using Statview software.
###end p 20
###begin title 21
RESULTS & DISCUSSION
###end title 21
###begin p 22
###xml 470 477 470 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 796 803 796 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 857 862 <span type="species:ncbi:9606">human</span>
###xml 926 932 <span type="species:ncbi:9913">bovine</span>
To investigate whether AMPK mediates VEGF-stimulated NO synthesis, we first determined the effects of physiological concentrations of VEGF on AMPK activity and eNOS Ser1177 phosphorylation in HAECs. VEGF (10ng/ml) elicited a transient, concomitant activation of AMPK and eNOS phosphorylation at Ser1177, which reached a maximum 2.8-fold and 3.6-fold stimulation respectively after 5 minutes. Both AMPK activity and eNOS phosphorylation rapidly returned to basal levels (Fig. 1A). In addition, activation of AMPK and phosphorylation of eNOS at Ser1177 by VEGF shared a similar dose-dependence, such that AMPK activity and eNOS Ser1177 phosphorylation were stimulated maximally (2.5-fold and 3.6-fold respectively) by 10 ng/ml VEGF, a concentration at which all further experiments were performed (Fig. 1B). Previous studies have reported that stimulation of human umbilical vein endothelial cells (HUVECs) with VEGF for 6 h or bovine aortic endothelial cells (BAECs) with VEGF for 10 min was without effect on phosphorylation of AMPK at Thr172 [15,19]. These studies are in agreement with the present study in which VEGF-stimulated AMPK activity peaked after 5 min incubation and returned to basal values within 15 min.
###end p 22
###begin p 23
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 517 523 517 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">20</xref>
PI3K, PLC and c-Src are known effectors of VEGF signalling in endothelial cells and previous studies have suggested that AMPK stimulation is downstream of PI3K and c-Src activation in peroxynitrite- and metformin-treated BAECs [16,19]. In the current study inhibition of either PI3K or c-Src had no effect on VEGF-stimulated AMPK activity in HAECs, suggesting that neither PI3K nor c-Src mediate VEGF-stimulated AMPK activation (Fig. 2A). Preincubation with U73122 completely inhibited VEGF-stimulated AMPK activity (Fig. 2), suggesting that VEGF stimulates AMPK in a PLC-dependent manner. Similarly, histamine has previously been reported to activate AMPK in HUVECs in a PI3K- independent, PLC-dependent manner [20].
###end p 23
###begin p 24
###xml 109 111 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 150 152 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">11</xref>
###xml 153 155 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 333 335 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 415 417 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 418 419 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 420 422 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22">22</xref>
###xml 500 506 493 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig 2A</xref>
###xml 722 729 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 941 948 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2B</xref>
###xml 1209 1216 1188 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2C</xref>
###xml 1285 1287 1264 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
It is now apparent that CaMKKbeta can act as an alternate upstream kinase to LKB1 that activates AMPK in a Ca2+-dependent and AMP-independent manner [11-13]. A recent report indicates that CaMKK mediates thrombin-stimulated AMPK activation in HUVECs, but that AMPK does not underlie thrombin-stimulated eNOS Ser1177 phosphorylation [21]. As VEGF is known to stimulate PLCgamma-mediated increases in intracellular Ca2+[3,22] and VEGF-stimulated AMPK activity is inhibited by the PLC inhibitor U73122 (Fig 2A), we examined whether VEGF-stimulated AMPK activity was mediated by CaMKK activation by using the CaMKK inhibitor, STO-609. Preincubation of HAECs with STO-609 reduced VEGF-stimulated AMPK activity to basal levels (Fig. 2A), without altering AICAR-stimulated AMPK activity, which is mediated by LKB1 (data not shown). VEGF-stimulated AMPK Thr172 phosphorylation was similarly reduced to basal levels after preincubation with STO-609 (Fig. 2B). STO-609 inhibits both CaMKKalpha and CaMKKbeta, yet the expression of these isoforms in endothelial cells has not previously been determined. Using isoform-specific anti-CaMKK antibodies, we demonstrated expression of both CaMKKalpha and CaMKKbeta in HAECs (Fig. 2C). These data indicate that VEGF stimulates CaMKK via PLC-mediated Ca2+mobilisation, and that CaMKK, rather than LKB1 is the upstream kinase responsible for AMPK activation in response to VEGF in endothelial cells.
###end p 24
###begin p 25
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">6</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">7</xref>
###xml 575 581 563 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 906 912 878 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1218 1224 1182 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
To determine the functional effects of VEGF-stimulated AMPK activity, we investigated the role of AMPK in VEGF-stimulated eNOS phosphorylation and NO production. Previous studies have proposed that VEGF-stimulated eNOS phosphorylation at Ser1177 is mediated by PKB [5,6], yet complete inhibition of PKB with the PI3K inhibitor, wortmannin only partially inhibited VEGF-stimulated NO production [3,5,7]. In agreement with this, preincubation of HAECs with the PI3K inhibitor wortmannin incompletely but significantly reduced VEGF-stimulated NO production by approximately65% (Fig. 3) at a concentration that completely inhibited phosphorylation of PKB at Ser473 (data not shown). These data suggest that both PI3K/PKB and a PI3K-independent kinase mediate VEGF-stimulated NO production. Infection of HAECs with Ad.alpha1DN caused a significant (approximately40%) reduction in VEGF-stimulated NO production (Fig. 3). In the presence of wortmannin, infection with Ad.alpha1DN significantly reduced VEGF-stimulated NO production to basal levels. Quantification of eNOS phosphorylation status in Ad.alpha1DN-infected cells revealed VEGF stimulated phosphorylation at Ser1177 was significantly reduced by approximately 70% (Fig. 4).
###end p 25
###begin p 26
###xml 276 282 272 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 678 680 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">11</xref>
###xml 773 775 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">23</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
ACC is phosphorylated by AMPK at Ser80 in ACC1 and Ser 220 in ACC2 (human sequence). Using an antibody that recognises both phosphorylated species, we demonstrated that VEGF stimulates phosphorylation of ACC, an effect completely inhibited in HAECs infected with Ad.alpha1DN (Fig. 4). These data indicate that infection with Ad.alpha1DN completely inhibits VEGF-stimulated AMPK activity. We were unable to distinguish whether the band represented ACC1, ACC2 or both. Inhibition of ACC1/ACC2 by phosphorylation at Ser80/Ser221 has been demonstrated to inhibit fatty acid synthesis in adipose tissue and liver whilst stimulating fatty acid oxidation in heart and skeletal muscle [11]. Activation of AMPK with AICAR has been shown to stimulate fatty acid oxidation in HUVECs [23], so it remains possible that VEGF transiently stimulates fatty acid oxidation due to AMPK-mediated phosphorylation of ACC.
###end p 26
###begin p 27
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 776 778 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 921 927 917 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1168 1169 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
Inhibition of VEGF-stimulated eNOS Ser1177 phosphorylation has previously been reported in HUVECs infected with adenoviruses expressing either dominant negative PKB or dominant negative AMPK under conditions of hypoxia, while under normoxic conditions, dominant negative AMPK was without effect [15]. In contrast, we have demonstrated that AMPK contributes to VEGF-stimulated eNOS phosphorylation and NO production under normoxic conditions (Figs. 3 & 4). Given the effects of wortmannin and Ad.alpha1DN, we propose that VEGF stimulates both PKB and AMPK-mediated phosphorylation of eNOS at Ser1177 under normoxic conditions. Similarly, both PKB and AMPK-mediated phosphorylation of eNOS at Ser1177 has previously been suggested to occur in response to adiponectin in HUVECs [18]. As incubation of HAECs with wortmannin does not alter AMPK activity, AMPK does not act downstream of PI3K in the response to VEGF in HAECs (Fig. 2). It remains possible that AMPK could act upstream of PKB in VEGF-stimulated eNOS phosphorylation, but this seems unlikely because we have previously demonstrated that infection with Ad.alpha1DN does not alter PKB phosphorylation in HAECs [9].
###end p 27
###begin p 28
In conclusion, we have demonstrated for the first time that VEGF stimulates the transient activation of AMPK in cultured endothelial cells in a PLC- and CaMKK-dependent manner. AMPK therefore represents a novel component of VEGF signalling. In addition we propose that AMPK represents the PI3K-independent kinase that contributes, along with activated PKB to VEGF-stimulated eNOS Ser1177 phosphorylation and subsequent NO production.
###end p 28
###begin title 29
ACKNOWLEDGEMENTS
###end title 29
###begin p 30
This work was supported by Diabetes UK (fellowship to I.P.S), grants from the British Heart Foundation and TENOVUS-Scotland (I.P.S), and by a Programme Grant from the Wellcome Trust and the EXGENESIS Integrated Project (LSHM-CT-2004-005272) funded by the European Commission (D.G.H).
###end p 30
###begin title 31
REFERENCES
###end title 31
###begin article-title 32
The biology of VEGF and its receptors
###end article-title 32
###begin article-title 33
VEGF-receptor signal transduction
###end article-title 33
###begin article-title 34
###xml 106 111 <span type="species:ncbi:9606">human</span>
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
###end article-title 34
###begin article-title 35
The Akt kinase signals directly to endothelial nitric oxide synthase
###end article-title 35
###begin article-title 36
Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways
###end article-title 36
###begin article-title 37
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
###end article-title 37
###begin article-title 38
Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric oxide synthase activation in cardiac capillary endothelial cells
###end article-title 38
###begin article-title 39
AMP-activated protein kinase phosphorylation of endothelial NO synthase
###end article-title 39
###begin article-title 40
###xml 87 92 <span type="species:ncbi:9606">human</span>
Direct activation of AMP-activated protein kinase stimulates nitric oxide synthesis in human aortic endothelial cells
###end article-title 40
###begin article-title 41
Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade
###end article-title 41
###begin article-title 42
AMP-activated protein kinase--development of the energy sensor concept
###end article-title 42
###begin article-title 43
Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase
###end article-title 43
###begin article-title 44
Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells
###end article-title 44
###begin article-title 45
Adiponectin stimulates production of nitric oxide in vascular endothelial cells
###end article-title 45
###begin article-title 46
AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress
###end article-title 46
###begin article-title 47
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo
###end article-title 47
###begin article-title 48
AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress
###end article-title 48
###begin article-title 49
Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells
###end article-title 49
###begin article-title 50
###xml 137 143 <span type="species:ncbi:9913">bovine</span>
Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3'- kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells
###end article-title 50
###begin article-title 51
Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt
###end article-title 51
###begin article-title 52
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta
###end article-title 52
###begin article-title 53
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
###end article-title 53
###begin article-title 54
###xml 77 82 <span type="species:ncbi:9606">human</span>
Acute regulation of fatty acid oxidation and AMP-activated protein kinase in human umbilical vein endothelial cells
###end article-title 54
###begin title 55
Figures
###end title 55
###begin p 56
Effect of VEGF on AMPK activity and eNOS Ser1177 phosphorylation.
###end p 56
###begin p 57
A) HAECs were incubated with 10 ng/ml VEGF for various times and lysates prepared. B) HAECs were incubated with the indicated concentrations of VEGF for 5 minutes and lysates prepared. Total AMPK was immunoprecipitated from endothelial cell lysates and assayed for AMPK activity. In parallel experiments, lysates were subjected to SDS PAGE, transferred to nitrocellulose and probed with the antibodies indicated. The intensity of the resultant bands was quantified using NIH Image software. Representative immunoblots are shown, repeated with similar results on 3 different samples of lysates. The results are expressed as the mean +/- SD % basal AMPK activity (â– ) or % basal eNOS phosphorylation (o) for three independent experiments. * p<0.01 relative to value in absence of VEGF. # p<0.05 relative to value in absence of VEGF.
###end p 57
###begin p 58
Effect of inhibitors of PLC and CaMKK on VEGF-stimulated AMPK activity
###end p 58
###begin p 59
###xml 941 944 <span type="species:ncbi:10116">rat</span>
HAECs were incubated in the presence or absence of 10 ng/ml VEGF for 5 minutes after preincubation with 100 nM wortmannin, 1 muM PP1, 10 muM U73122 or 25 muM STO-609 for 45 minutes and lysates prepared. A) Total AMPK was immunoprecipitated from HAEC lysates and assayed for AMPK activity. The results are expressed as the mean +/- SD % basal AMPK activity for four independent experiments. * p<0.01 relative to value in absence of inhibitor. B) AMPK immunoprecipitates were resolved by SDS-PAGE, transferred to nitrocellulose and probed with the antibodies indicated. Representative immunoblots are shown, repeated with similar results on 4 different samples of lysates. C) HAEC lysates were resolved by SDS PAGE, transferred to nitrocellulose and probed with anti-CaMKKalpha antibodies. CaMKKbeta was immunoprecipitated from HAEC lysate, subjected to Western blotting and probed with anti-CaMKKbeta antibodies. A lysate prepared from whole rat brain was used as a positive control. Representative immunoblots are shown.
###end p 59
###begin p 60
The effects of infection with Ad.alpha1DN on VEGF-stimulated NO production
###end p 60
###begin p 61
###xml 180 183 176 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 277 278 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 278 279 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
HAECs were infected with 25 Pfu/cell of Ad.Null or Ad.alpha1DN viruses 24 h prior to experimentation. Cells were incubated in KRH buffer in the presence or absence of 10 ng/ml VEGF165 and/or 100 nM wortmannin. After 15 min, media was removed and assayed for L-NAME-sensitive NO2- content. The data shown represents the mean +/- SD NO synthesis from 9 independent experiments. * p<0.05 relative to value in Ad.Null-infected cells.
###end p 61
###begin p 62
The effects of infection with Ad.alpha1DN on VEGF-stimulated ACC and eNOS phosphorylation.
###end p 62
###begin p 63
HAECs were infected with 25 Pfu/cell of Ad.alpha1DN or Ad.Null 24 h prior to experimentation. Subsequently, HAEC lysates were prepared from cells incubated in the presence or absence of 10 ng/ml VEGF, resolved by SDS PAGE, transferred to nitrocellulose and probed with the antibodies indicated. Specific band intensities were quantified using NIH Image software. Representative immunoblots are shown, repeated with similar results on 4 different samples of lysates.
###end p 63

